Aurora Cannabis’ (ACB-Toronto) released its year-end MD&A and financial statements last week. Issues previously discussed, including questionable disclosures, a limited German market, questionable vertical integration, a lack of operating leverage, excessive shipping costs and oil extraction costs continue to play out as expected.
We have expanded our investor pitch to 61-slides in order to more appropriately cover the increasing number of issues with Aurora. Again our coverage of Aurora Cannabis is being made public for marketing purposes.
By accessing our investor pitch on Google Drive, you agree to allow Perspectec to contact you via email for marketing purposes. We do not disclose your email to any external parties.
https://drive.google.com/file/d/16coTW8KOf4RNLcj4In0vX2bXUmJLRuSd/view?usp=sharing
